Atrandi Biosciences is a series a startup. 1 investor tracked.
Atrandi Biosciences is a startup based in Spain. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Atrandi Biosciences develops innovative microfluidic technologies for single-cell analysis and high-throughput screening in the fields of drug discovery, synthetic biology, and diagnostics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.